Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 18, 2007, Pages 3217-3235

  Kranke, Peter ^a   Schuster, Frank ^a   Eberhart, Leopold H ^b  

^a University Hospitals of Wüürzburg   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

antiemetic algorithm; perioperative period; postoperative nausea and vomiting (PONV); prevention; risk assessment; treatment

Indexed keywords

ANTIEMETIC AGENT; APREPITANT; DEXAMETHASONE; ISOQUINOLINE DERIVATIVE; MORPHOLINE DERIVATIVE; NEUROKININ 1 RECEPTOR; PALONOSETRON; QUINUCLIDINE DERIVATIVE; SEROTONIN ANTAGONIST;

ALGORITHM; DRUG ANTAGONISM; DRUG COMBINATION; ECONOMICS; HUMAN; POSTOPERATIVE NAUSEA AND VOMITING; REVIEW; RISK ASSESSMENT;

ALGORITHMS; ANTIEMETICS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; HUMANS; ISOQUINOLINES; MORPHOLINES; POSTOPERATIVE NAUSEA AND VOMITING; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; RISK ASSESSMENT; SEROTONIN ANTAGONISTS;

EID: 40949159882     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.8.18.3217     Document Type: Review

References (102)

1. EBERHART LH, MORIN AM, WULF H, GELDNER G: Patient preferences for immediate postoperative recovery. Br. J. Anaesth. (2002) 89:760-761.
2. CLERGUE F, AUROY Y, PEQUIGNOT F, JOUGLA E, LIENHART A, LAXENAIRE MC: French survey of anesthesia in 1996. Anesthesiology (1999) 91:1509-1520.
3. KRANKE P, MORIN A, VOGEL H, KRANKE E, ROEWER N, EBERHART L: Clinical and economic effi ciency of approaches to prevent PONV. Anesth. Analg. (2006) 102:S133.
4. ZHANG GS, MATHURA JR: Images in clinical medicine: painless loss of vision after vomiting. N. Engl. J. Med. (2005) 352:E16.
5. ANTONIS JH, POEZE M, VAN HEURN LW: Boerhaave's syndrome in children: a case report and review of the literature. J. Pediatr. Surg. (2006) 41:1620-1623.
6. COL C, SORAN A, COL M: Can postoperative abdominal wound dehiscence be predicted? Tokai J. Exp. Clin. Med. (1998) 23:123-127.
7. TEMES R, FETEIHA M, MAPEL D, CROWELL R, KETAI L, WERNLY J: Esophageal rupture after regional anesthesia: report of two cases. J. Clin. Gastroenterol. (1999)28:360-363.
8. TOPRAKV, KELES GT, KAYGISIZZ, TOK D: Subcutaneous emphysema following severe vomiting after emerging from general anesthesia. Acta Anaesthesiol. Scand. (2004) 48:917-918.
9. SCHUMANN R, POLANER DM: Massive subcutaneous emphysema and sudden airway compromise after postoperative vomiting. Anesth. Analg. (1999) 89:796.
10. MYLES PS, WILLIAMS DL, HENDRATA M, ANDERSON H, WEEKS AM: Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br. J. Anaesth. (2000) 84:6-10.
11. MACARIO A, WEINGER M, CARNEY S, KIM A: Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth. Analg. (1999) 89:652-658.
12. GAN T, SLOAN F, DEAR GL, EL-MOALEM HE, LUBARSKY DA: How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth. Analg. (2001) 92:393-400.
13. SENNARAJ B, SHENDE D, SADHASIVAM S, ILAVAJADY S, JAGAN D: Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes. Br. J. Anaesth. (2002) 89:473-478.
14. SCUDERI PE, JAMES RL, HARRIS L, MIMS GR III: Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment. Anesthesiology (1999) 90:360-371.
15. EBERHART LH, BOTHNER U, BÜNDGEN W et al : Cross-validation of simple questioning methods to determine patient satisfaction with anaesthesia care. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. (2004) 39:406-411.
16. GOLD BS, KITZ DS, LECKYJH, NEUHAUS JM: Unanticipated admission to the hospital following ambulatory surgery. JAMA (1989) 262:3008-3010.
17. FORTIERJ, CHUNG F, SU J: Unanticipated admission after ambulatory surgery-a prospective study. Can. J. Anaesth. (1998)45:612-619.
18. MEEKS GR, WALLER GA, MEYDRECH EF, FLAUTT FH Jr: Unscheduled hospital admission following ambulatory gynecologic surgery Obstet. Gynecol. (1992) 80:446-450.
19. JENSEN K, KEHLET H, LUND CM: Post-operative recovery profi le after laparoscopic cholecystectomy: a prospective, observational study of a multimodal anaesthetic regime. Acta Anaesthesiol. Scand. (2007) 51:464-471.
20. EBERHART LHJ, MORIN AM, FELBINGER TW, FALKNER Y, GEORGIEFF M, SEELING W: Results of a survey of anesthetists on postoperative nausea and vomiting. Anaesth. Intensivmed. Notfallmed. Schmerzther. (1998) 33:545-551.
21. APFEL CC, ROEWER N: Risk assessment of postoperative nausea and vomiting. Int. Anesthesiol Clin. (2003) 41:13-32.
22. GAN TJ: Risk factors for postoperative nausea and vomiting. Anesth. Analg. (2006) 102:1884-1898.
23. TRAMÈR MR, MOORE A, MCQUAY H: Omitting nitrous oxide in general anaesthesia: meta-analysis of intraoperative awareness and postoperative emesis in randomized controlled trials. Br. J. Anaesth. (1996) 76:186-193.
24. PALAZZO M, EVANS R: Logistic regression analysis of fi xed patient factors for postoperative sickness: a model for risk assessment. Br. J. Anaesth. (1993) 70:135-140.
25. APFEL CC, LÄÄRÄ E, KOIVURANTA M, GREIM CA, ROEWER N: A simplifi ed risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology (1999) 91:693-700.
26. TONER CC, BROOMHEAD CJ, LITTLEJOHN IH et al. : Prediction of postoperative nausea and vomiting using a logistic regression model. Br. J. Anaesth. (1996) 76:347-351.
27. APFEL CC, GREIM CA, HAUBITZ I et al: The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol. Scand. (1998) 42:502-509.
28. APFEL CC, GREIM CA, HAUBITZ I et al : A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol. Scand. (1998) 42:495-501.
29. KOIVURANTA M, LÄÄRÄ E, SNARE L, ALAHUHTA S: A survey of postoperative nausea and vomiting. Anaesthesia (1997) 52:443-449.
30. EBERHART LH, GELDNER G, KRANKE P et al.: The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth. Analg. (2004) 99:1630-1637.
31. KRANKE P, EBERHART LH, TOKER H, ROEWER N, WULF H, KIEFER P: Prospective evaluation of the POVOV-Score for the prediction of postoperative vomiting in children. Anesth. Analg. (2007) 105 (In press).
32. KRANKE P, APFEL CC, PAPENFUSS T et al : An increased body mass index is no risk factor for postoperative nausea and vomiting. A systematic review and results of original data. Acta Anaesthesiol. Scand. (2001) 45:160-166.
33. EBERHART LH, MORIN AM, GEORGIEFF M: The menstruation cycle in the postoperative phase. Its effect of the incidence of nausea and vomiting. Anaesthesist (2000) 49:532-535.
34. ENGEL JM, JUNGER A, HARTMANN B et al : Performance and customization of 4 prognostic models for postoperative onset of nausea and vomiting in ear, nose, and throat surgery. J. Clin. Anesth. (2006) 18:256-263.
35. VAN DEN BOSCH JE, KALKMAN CJ, VERGOUWE Y et al. : Assessing the applicability of scoring systems for predicting postoperative nausea and vomiting. Anaesthesia (2005) 60:323-331.
36. APFEL CC, EBERHART LHJ, KRANKE P, R Ü SCH D: Recommendations for randomized controlled trials to prevent or treat postoperative nausea and vomiting. Anaesthesiol. Intensivmed. (2002) 43:69-74.
37. TRAEGERM, EBERHART A, GELDNER G et al : Prediction of postoperative nausea and vomiting using an artifi cial neural network. Anaesthesist (2003) 52:1132-1138.
38. PENG SY, WU KC, WANG JJ, CHUANG JH, PENG SK, LAI YH: Predicting postoperative nausea and vomiting with the application of an artifi cial neural network. Br. J. Anaesth. (2007) 98:60-65.
39. APFEL CC, KRANKE P, GREIM CA, ROEWER N: What can be expected from risk scores for predicting postoperative nausea and vomiting? Br. J. Anaesth. (2001) 86:822-827.
40. PIERRE S, CORNO G, BENAIS H, APFEL CC: A risk score-dependent antiemetic approach effectively reduces postoperative nausea and vomiting-a continuous quality improvement initiative. Can. J. Anaesth. (2004) 51:320-325.
41. RÜSCH D, EBERHART L, BIEDLER A, DETHLING J, APFEL CC: Prospective application of a simplifi ed risk score to prevent postoperative nausea and vomiting. Can. J. Anaesth. (2005) 52:478-484.
42. BIEDLER A, WERMELT J, KUNITZ O et al : A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. Can. J. Anaesth. (2004) 51:13-19.
43. KRANKE P, EBERHART LH, GAN TJ, ROEWER N, TRAMÈR MR: Algorithms for the prevention of postoperative nausea and vomiting: an effi cacy and effi ciency simulation. Eur. J. Anaesthesiol. (2007) 24 :856-867.
44. GAN TJ, MEYER T, APFEL CC et al: Society for ambulatory anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth. Analg. (2007) 105 (In press).
45. APFEL CC, KORTTILA K, ABDALLA M et al : A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N. Engl. J. Med. (2004) 350:2441-2451.
46. TRAMÈR MR, WALDER B: Number needed to treat (or harm). World J. Surg. (2005) 29:576-581.
47. TRAMÈR MR: A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part 1. Effi cacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiol. Scand. (2001) 45:4-13.
48. CARLISLE JB, STEVENSON CA: Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst. Rev. (2006) 3:CD004125.
49. HENZI I, WALDER B, TRAMÈR MR: Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br. J. Anaesth. (1999) 83:761-771.
50. GEHR BT, WEISS C, PORZSOLT F: The fading of reported effectiveness. A meta-analysis of randomised controlled trials. BMC Med. Res. Methodol (2006) 6:25.
51. WALLENBORN J, GELBRICH G, BULST D et al : Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial. BMJ (2006) 333:324-329.
52. QUAYNOR H, RAEDER JC: Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol. Scand. (2002) 46:109-113.
53. WANG JJ, HO ST, TZENG JI, TANG CS: The effect of timing of dexamethasone administration on its effi cacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth. Analg. (2000) 91:136-139.
54. RÜSCH D, ARNDT C, MARTIN H, KRANKE P: The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Anaesthesia (2007) 62:810-817.
55. SUZUKI T, SUGIMOTO M, KOYAMA H, MASHIMO T, UCHIDA I: Inhibitory effect of glucocorticoids on human-cloned 5-hydroxytryptamine3A receptor expressed in xenopus oocytes. Anesthesiology (2004) 101:660-665.
56. MACARIO A, CHUNG A, WEINGER MB: Variation in practice patterns of anesthesiologists in California for prophylaxis of postoperative nausea and vomiting. J. Clin. Anesth. (2001) 13:353-360.
57. EBERHART LH, MORIN AM, GEORGIEFF M: Dexamethasone for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomized controlled studies. Anaesthesist (2000) 49:713-720.
58. HENZI I, WALDER B, TRAMÈR MR: Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth. Analg. (2000) 90:186-194.
59. GOLDMAN AC, GOVINDARAJ S, ROSENFELD RM: A meta-analysis of dexamethasone use with tonsillectomy Otolaryngol. Head Neck Surg. (2000) 123:682-686.
60. STEWARD DL, WELGE JA, MYER CM: Do steroids reduce morbidity of tonsillectomy? Meta-analysis of randomized trials. Laryngoscope (2001) 111:1712-1718.
61. STEWARD DL, WELGE JA, MYER CM: Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst. Rev. (2003):CD003997.
62. AFMAN CE, WELGE JA, STEWARD DL: Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials. Otolaryngol. Head Neck Surg. (2006) 134:181-186.
63. BISGAARD T, KLARSKOV B, KEHLET H, ROSENBERG J: Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann. Surg. (2003) 238:651-660.
64. APRIL MM, CALLAN ND, NOWAK DM, HAUSDORFF MA: The effect of intravenous dexamethasone in pediatric adenotonsillectomy. Arch. Otolaryngol. Head Neck Surg. (1996) 122:117-120.
65. PAPPAS AL, SUKHANI R, HOTALING AJ et al. : The effect of preoperative dexamethasone on the immediate and delayed postoperative morbidity in children undergoing adenotonsillectomy. Anesth. Analg. (1998) 87:57-61.
66. THAGAARD KS, JENSEN HH, RAEDER J: Analgesic and antiemetic effect of ketorolac vs. β-methasone or dexamethasone after ambulatory surgery. Acta Anaesthesiol. Scand. (2007) 51:271-277.
67. AASBOE V, RAEDER JC, GROEGAARD B: β-methasone reduces postoperative pain and nausea after ambulatory surgery. Anesth. Analg. (1998) 87:319-323.
68. BLUMING AZ, ZEEGEN P: Cataracts induced by intermittent decadron used as an antiemetic. J. Clin. Oncol. (1986) 4:221-223.
69. VEYRAT-FOLLET C, FARINOTTI R, PALMER JL: Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds. Drugs (1997) 53:206-234.
70. DIEMUNSCH P, GRELOT L: Potential of substance P antagonists as antiemetics. Drugs (2000) 60:533-546.
71. GESZTESI Z, SCUDERI PE, WHITE PF et al. : Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology (2000) 93:931-937.
72. DIEMUNSCH P, SCHOEFFLER P, BRYSSINE B et al. : Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Br. J. Anaesth. (1999) 82:274-276.
73. GRALLA RJ, ROILA F, TONATO M: The 2004 Perugia antiemetic consensus guideline process: methods, procedures, and participants. Support. Care Cancer (2005) 13:77-79.
74. TATTERSALL FD, RYCROFT W, HILL RG, HARGREAVES RJ: Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin 1 receptor antagonist CP-99,994. Neuropharmacology (1994) 33:259-260.
75. MOORE S,TUMEH J, WOJTANOWSKI S, FLOWERS C: Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy. Value Health (2007) 10:23-31.
76. GRALLA RJ, DE WIT R, HERRSTEDT J et al. : Antiemetic effi cacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials. Cancer (2005) 104:864-868.
77. GAN TJ, APFEL CC, KOVAC A et al.: A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth. Analg. (2007) 104:1082-1089.
78. DIEMUNSCH P, GAN TJ, PHILIP BK et al. : Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery. Br. J. Anaesth. (2007) 99:202-211.
79. KOVAC A, EBERHART L, KOTARSKI J, NOVOTNY Z, APFEL C: Palonosetron is effective in preventing PONV/PDNV for up to 3 days following surgery. Anesthesiology (2007):A52 (ASA Abstract).
80. EBERHART LH, MORIN AM, BOTHNER U, GEORGIEFF M: Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials. Acta Anaesthesiol. Scand. (2000) 44:1252-1257.
81. EBERHART LH, MORIN AM, GEORGIEFF M: Dexamethason zur Prophylaxe von belkeit und Erbrechen in der postoperativen Phase-Eine Meta analyse kontrollierter randomisierter Studien. Anaesthesist (2000) 49:713-720.
82. HABIB AS, EL-MOALEM HE, GAN TJ: The effi cacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can. J. Anaesth. (2004) 51:311-319.
83. HEFFERNANAM, ROWBOTHAM DJ: Postoperative nausea and vomiting-time for balanced antiemesis? Br. J. Anaesth. (2000) 85:675-677.
84. SCUDERI PE, JAMES RL, HARRIS L, MIMS GR III: Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy Anesth. Analg. (2000) 91:1408-1414.
85. EBERHART LH, MAUCH M, MORIN AM, WULF H, GELDNER G: Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia (2002) 57:1022-1027.
86. HABIB AS, GANTJ: Combination antiemetics: what is the evidence? Int. Anesthesiol. Clin. (2003)41:119-144.
87. HABIB AS, WHITE WD, EUBANKS S, PAPPAS TN, GAN TJ: A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesth. Analg. (2004) 99:77-81.
88. CANDIOTTI KA, BIRNBACH DJ, LUBARSKY DA et al : The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology (2005) 102:543-549.
89. JANICKI PK, SCHULER HG, JARZEMBOWSKI TM, ROSSI M: Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype. Anesth. Analg. (2006) 102:1127-1133.
90. KAISER R, SEZER O, PAPIES A et al: Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J. Clin. Oncol. (2002) 20:2805-2811.
91. SHAH J: Criteria infl uencing the clinical uptake of pharmacogenomic strategies. BMJ (2004) 328:1482-1486.
92. KAZEMI-KJELLBERG F, HENZI I, TRAMÈR MR: Treatment of established postoperative nausea and vomiting: a quantitative systematic review BMC Anesthesiol. (2001) 1:2.
93. TRAMÈR MR, MOORE RA, REYNOLDS DJ, MCQUAY HJ: A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting. BMJ (1997) 314:1088-1092.
94. EBERHART LH, FRANK S, LANGE H et al : Systematic review on the recurrence of postoperative nausea and vomiting after a fi rst episode in the recovery room-implications for the treatment of PONV and related clinical trials. BMC Anesthesiol. (2006) 6:14.
95. KOVACAL, O'CONNOR TA, PEARMAN MH et al: Effi cacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. J. Clin. Anesth. (1999) 11:453-459.
96. HABIB AS, GAN TJ: The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J. Clin. Anesth. (2005) 17:62-65.
97. HABIB AS, REUVENI J, TAGUCHI A, WHITE WD, GAN TJ: A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis. Anesth. Analg. (2007) 104:548-551.
98. DE WIT R, DE BOER AC, VAN DEN LINDEN GH, STOTER G, SPARREBOOM A, VERWEIJ J: Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the fi rst 24 h following highly emetogenic chemotherapy. Br. J. Cancer (2001) 85:1099-1101.
99. CANDIOTTI KA, NHUCH F, KAMAT A et al. : Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study. Anesth. Analg. (2007) 104:1370-1373.
100. MACARIO A, CLAYBON L, PERGOLIZZI JV: Anesthesiologists' practice patterns for treatment of postoperative nausea and vomiting in the ambulatory post anesthesia care unit. BMC Anesthesiol. (2006) 6:6.
101. HAMMAS B, THORN SE, WATTWIL M: Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen-comparison with propofol or placebo. Acta Anaesthesiol. Scand. (2002) 46:232-237.
102. RÜSCH D, BIALLAS R, WULF H: Kombinationsprophylaxe von Ü belkeit und Erbrechen nach Fadenoperationen in der Strabismuschirurgie bei Kindern durch TIVA plus Dimenhydrinat, Dolasetron und Dexamethason. Anaesthesiol. Intensivmed. (2001) 42 :S. 519-PO 3-D.1.